Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer
Public ClinicalTrials.gov record NCT02874885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Circulating Tumor Elements in Patients With Rectal Cancer
Study identification
- NCT ID
- NCT02874885
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Enrollment
- 341 participants
Conditions and interventions
Conditions
- Locally Advanced Rectal Adenocarcinoma
- Metastatic Rectal Adenocarcinoma
- Rectosigmoid Adenocarcinoma
- Recurrent Rectal Adenocarcinoma
- Recurrent Rectosigmoid Carcinoma
- Stage III Rectal Cancer AJCC v8
- Stage IIIA Rectal Cancer AJCC v8
- Stage IIIB Rectal Cancer AJCC v8
- Stage IIIC Rectal Cancer AJCC v8
- Stage IV Rectal Cancer AJCC v8
- Stage IVA Rectal Cancer AJCC v8
- Stage IVB Rectal Cancer AJCC v8
- Stage IVC Rectal Cancer AJCC v8
Interventions
- Biospecimen Collection Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 4, 2013
- Primary completion
- Apr 29, 2027
- Completion
- Apr 29, 2027
- Last update posted
- Mar 10, 2026
2013 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02874885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02874885 live on ClinicalTrials.gov.